Deep-pocketed investors have adopted a bullish approach towards Zoetis ZTS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ZTS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Zoetis. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 4 are puts, totaling $327,774, and 4 are calls, amounting to $220,960.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $165.0 to $180.0 for Zoetis over the recent three months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Zoetis options trades today is 704.83 with a total volume of 3,189.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Zoetis's big money trades within a strike price range of $165.0 to $180.0 over the last 30 days.
Zoetis Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZTS | PUT | SWEEP | BEARISH | 04/19/24 | $2.4 | $2.05 | $2.35 | $165.00 | $199.3K | 2.5K | 1.0K |
| ZTS | CALL | SWEEP | BULLISH | 05/17/24 | $8.3 | $8.0 | $8.3 | $165.00 | $83.0K | 79 | 114 |
| ZTS | PUT | SWEEP | BEARISH | 04/19/24 | $2.4 | $2.1 | $2.4 | $165.00 | $66.0K | 2.5K | 1.3K |
| ZTS | CALL | SWEEP | BULLISH | 05/17/24 | $3.7 | $3.4 | $3.6 | $175.00 | $54.3K | 416 | 361 |
| ZTS | CALL | SWEEP | BULLISH | 05/17/24 | $5.0 | $4.8 | $5.0 | $170.00 | $50.0K | 434 | 116 |
About Zoetis
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Following our analysis of the options activities associated with Zoetis, we pivot to a closer look at the company's own performance.
Current Position of Zoetis
- With a trading volume of 1,603,372, the price of ZTS is up by 0.58%, reaching $163.92.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 28 days from now.
Expert Opinions on Zoetis
1 market experts have recently issued ratings for this stock, with a consensus target price of $195.0.
- An analyst from Stifel persists with their Buy rating on Zoetis, maintaining a target price of $195.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Zoetis options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
